What does PD-L1 positive or negative mean?

por Ribas, Antoni, Hu-Lieskovan, Siwen
Publicado 2016

Gene editing: Towards the third generation of adoptive T-cell transfer therapies

por Puig-Saus, Cristina, Ribas, Antoni
Publicado 2019

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

por Ascierto, Paolo A, Marincola, Francesco M, Ribas, Antoni
Publicado 2011

Exosomes as a predictor tool of acquired resistance to melanoma treatment

por Goedert, Lucas, Koya, Richard, Hu-Lieskovan, Siwen, Ribas, Antoni
Publicado 2014

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

por Campbell, Katie M., Steiner, Gabriela, Wells, Daniel K., Ribas, Antoni, Kalbasi, Anusha
Publicado 2020

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma

por Homet Moreno, Blanca, Mok, Stephen, Comin-Anduix, Begonya, Hu-Lieskovan, Siwen, Ribas, Antoni
Publicado 2015

Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations

por Gentilcore, Giusy, Madonna, Gabriele, Mozzillo, Nicola, Ribas, Antoni, Cossu, Antonio, Palmieri, Giuseppe, Ascierto, Paolo A
Publicado 2013

BRAF-targeted therapy and immune responses to melanoma

por Ngiow, Shin Foong, Knight, Deborah A, Ribas, Antoni, McArthur, Grant A, Smyth, Mark J.
Publicado 2013

Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma

por Lassen, Amanda, Atefi, Mohammad, Robert, Lidia, Wong, Deborah JL, Cerniglia, Michael, Comin-Anduix, Begonya, Ribas, Antoni
Publicado 2014

Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

por Campbell, Katie M, Thaker, Maneesha, Medina, Egmidio, Kalbasi, Anusha, Singh, Arun, Ribas, Antoni, Nowicki, Theodore Scott
Publicado 2022

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

por von Euw, Erika, Chodon, Thinle, Attar, Narsis, Jalil, Jason, Koya, Richard C, Comin-Anduix, Begonya, Ribas, Antoni
Publicado 2009

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet

por Tavare, Richard, Escuin-Ordinas, Helena, McCracken, Melissa, Zettlitz, Kirstin, Salazar, Felix, Witte, Owen, Ribas, Antoni, Wu, Anna
Publicado 2015

Impact of COVID-19 Pandemic on Cancer Research

por Zon, Leonard, Gomes, Ana P., Cance, William G., Ribas, Antoni, Tuveson, David, Postel-Vinay, Sophie, Massard, Christophe, Barlési, Fabrice
Publicado 2020

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

por Mok, Stephen, Tsoi, Jennifer, Koya, Richard C, Hu-Lieskovan, Siwen, West, Brian L, Bollag, Gideon, Graeber, Thomas G, Ribas, Antoni
Publicado 2015

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

por Yan, Yibing, McArthur, Grant, Hamid, Omid, Puzanov, Igor, Gonzalez, Rene, Gajewski, Thomas, Wang, Yulei, Wongchenko, Matthew, Choong, Nicholas, Ribas, Antoni
Publicado 2014

A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell tra...

por Zhou, Jing, Bethune, Michael T., Malkova, Natalia, Sutherland, Alexander M., Comin-Anduix, Begonya, Su, Yapeng, Baltimore, David, Ribas, Antoni, Heath, James R.
Publicado 2018

Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance

por Su, Yapeng, Bintz, Marcus, Yang, Yezi, Robert, Lidia, Ng, Alphonsus H. C., Liu, Victoria, Ribas, Antoni, Heath, James R., Wei, Wei
Publicado 2019

Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesis

por Palaskas, Nicolaos Jay, Garcia, Jacob David, Shirazi, Roksana, Shin, Daniel Sanghoon, Puig-Saus, Cristina, Braas, Daniel, Ribas, Antoni, Graeber, Thomas Glen
Publicado 2019

Quantitative PET reporter gene imaging of CD8(+) T cells specific for a melanoma-expressed self-antigen

por Shu, Chengyi J., Radu, Caius G., Shelly, Stephanie M., Vo, Dan D., Prins, Robert, Ribas, Antoni, Phelps, Michael E., Witte, Owen N.
Publicado 2009

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

por Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Publicado 2012